Sign inJoin waitlistJoin the waitlist

Sujana Movva

Assistant Attending Physician · New York Presbyterian Hospital

Credentials: · · · · · ·

History

Memorial Hospital for Cancer and allied Diseases
2019–Present

Hematology and Medical Oncology
University of New Mexico-Main Campus
2006–2009
Internal Medicine
McLaren-Flint
2003–2006
UNIV OF WESTERN ONTARIO, FAC OF MED, LONDON, ONTARIO, CANADA
1999–2003

Research

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
The Lancet Oncology · 2017 · 1,203 citations
Sorafenib for Advanced and Refractory Desmoid Tumors
New England Journal of Medicine · 2018 · 355 citations
NCCN Guidelines Insights: Bone Cancer, Version 2.2017
Journal of the National Comprehensive Cancer Network · 2017 · 239 citations

WT
William Tap
28 papers
CK
Ciara Kelly
25 papers
MK
Mary Keohan
25 papers
Mrinal Gounder
25 papers
MD
Mark Dickson
24 papers
PC
Ping Chi
24 papers
SD
Sandra D'Angelo
24 papers · 13 as a resident
ER
Evan Rosenbaum
21 papers · 3 as a fellow
CA
Cristina Antonescu
18 papers
Samuel Singer
16 papers
JC
Jason Chang
14 papers · 14 as a fellow
RM
Robert Maki
14 papers

Clinical trials

A Study of Niraparib in People With Soft Tissue Sarcoma Who Have Changes in Their Tumor DNA
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2022–2027
Lenvatinib and Pembrolizumab in People With Advanced Soft Tissue Sarcoma
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2021–2027
A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2020–2026